William S. Staewen, a Johns Hopkins-trained biomedical engineer and co-inventor of the implantable heart defibrillator, died ...
The Brighterside of News on MSN
Scientists re-engineer a patient’s own T cells to target and destroy cancer cells
Hodgkin lymphoma and other malignancies that express the CD30 protein have been the scourge of oncologists for decades. For ...
Saudi Arabia-based healthtech Nuxera AI has secured $2.5 million in pre-seed investment from Sanabil Venture Studio ...
Secure, scalable, multi-cloud platform using federated learning aims to accelerate cancer discoveries and treatments SEATTLE, ...
MBI is partnered with a fast-growing medical device company is seeking a Field Clinical Engineer to join its European team based in either Germany, France, Switzerland or Italy. This role is pivotal ...
Edmonton’s Glenrose Hospital is helping startups turn prototypes into real patient care by embedding clinical feedback early ...
A New Model for the Modern Issuer BRISTOL, TN / ACCESS Newswire / October 7, 2025 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) is quietly redrawing the boundaries of what a biotechnology ...
Mayo Clinic's Division of AI and Systems Engineering develops machine learning, deep-learning and other data science tools ...
NTU Singapore launches four new Master's programmes leveraging advancements in AI Nanyang Technological University, Singapore (NTU Singapore) is launching four new master’s degree programmes in 2026 ...
Katy Rezvani, MD, PhD, discusses advancements in CAR-NK cell therapy, focusing on enhancing antitumor efficacy while ensuring safety through precise gene editing techniques.
Researchers at the University of Michigan are using artificial intelligence to predict the health consequences that ...
Company’s Phase 1/2 Clinical Trial of EN-374 in X-linked Chronic Granulomatous Disease is Now Open for Patient Enrollment BOSTON, September 22, 2025--(BUSINESS WIRE)--Ensoma, an in vivo hematopoietic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results